Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medicago Inc MDCGF



GREY:MDCGF - Post by User

Comment by blitzer2on Oct 04, 2012 2:21pm
209 Views
Post# 20448486

RE: RE: News: Medicago and Cellectis........

RE: RE: News: Medicago and Cellectis........

Pandora, I agree it's a little complex but, after digging around some, it appears in essence, to give it a quick snapshot perspective, that the Global Protein Therapeutics Market could get to a US$143 Billion Market by 2015. This, according to an article on the Before It's News website that mentions a new research report by RNCOS.

https://beforeitsnews.com/health/2012/04/global-protein-therapeutics-market-to-cross-us-143-billion-mark-by-2015-1996871.html

It would appear, as I understand it, that Biosimilars have made an entry into that market and that according to another research report mentioned on the the RNCOS website, the biosimilars industry has been growing fast across the globe for the past few years.

https://www.rncos.com/Report/IM379.htm

Check out the info on both these sites, particularly the RNCOS site where both Global Protein Therapeutics and Global Biosimilars reports are mentioned and are available. It might help to give you a little more insight on the potential scale and scope for the development of biosimilar protein therapeutics.

<< Previous
Bullboard Posts
Next >>